Market Size of Cell Counting Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 7.20 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Cell Counting Market Analysis
Over the next few years, the cell counting market is expected to register a CAGR of 7.2%.
COVID-19 had a significant impact on the adoption of cell-counting products and consumables. The pandemic witnessed increased adoption of cell counting devices, as osteopenia and lymphopenia were the potential indicators of COVID-19. The study, published in BMC Infectious Diseases in June 2021, found that in COVID-19 patients, a high WBC count upon admission was significantly linked to death. As a result, in the therapy of COVID-19, a higher WBC count should be given more consideration. Thus, the COVID-19 pandemic had a pronounced impact on the growth of the market. However, as the pandemic has subsided currently, the market is expected to experience stable growth over the forecast period of the study.
The major factors contributing to the market's growth are the rising incidence of target diseases like HIV, measles, diphtheria, and chronic diseases like cancer and other blood disorders; and the growing use of high-throughput flow cytometry and automated hematology analyzers.
According to the data from UNAIDS, in 2022, an estimated 38.4 million people worldwide were living with HIV, and an estimated 1.5 million people became newly infected with HIV in 2021. It was also stated that by 2021, 28.7 million people would have access to antiretroviral therapy. Thus, rising cases of infectious diseases are ultimately expected to increase the demand for cell counting products and consumables.
Furthermore, technological advancements in cell counting products and consumables have led to increased product launches and, thereby, increased adoption, in turn driving market growth. For instance, Logos Biosystems, a leading provider of cutting-edge life science solutions and a division of Aligned Genetics, Inc., officially launched the CountWire System in February 2021.
Therefore, the rising prevalence of chronic diseases, growing technological advancements, and product launches in the cell counting market, among others, are expected to drive the growth of this market. But the growth of the market is likely to be slowed by the high cost of advanced cell counting systems and product recalls of hematology analyzers.
